Korean J Med.  2009 Sep;77(3):275-281.

The management of chronic hepatitis C

Affiliations
  • 1Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Hepatitis C virus (HCV) infection remains a serious health problem, and an estimated 170 million people are infected worldwide. Hepatitis C is the principal cause of death from liver disease and is the one of the main indications for liver transplantation. The primary goal in the treatment of HCV infection is to reduce mortality by preventing liver-related deaths associated with the development of hepatocellular carcinoma and decompensated cirrhosis. PEGylated interferons, together with ribavirin, are currently the standard of care for patients with chronic hepatitis C. This review discusses the current indications and standard treatment of hepatitis C virus infection.

Keyword

Chronic hepatitis C; Treatment indication; Treatment

MeSH Terms

Carcinoma, Hepatocellular
Cause of Death
Fibrosis
Hepacivirus
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
Humans
Interferons
Liver Diseases
Liver Transplantation
Ribavirin
Standard of Care
Interferons
Ribavirin
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr